Sun Pharmaceutical Industries Q2 Results

  • BSE: 524715
  • NSE: SUNPHARMA
  • ISIN: INE044A01036
  • Sector: Biotechnology & Drugs
BSE
1,713.80-16.35 (-0.95%)
Volume33.92 K
Updated: Tue 20 May, 2025 | 15:29:45
NSE
1,707.80-22.40 (-1.29%)
Volume2.71 M
Updated: Tue 20 May, 2025 | 15:52:50
Today: 1,703.75
1,750.70
52-Wk: 1,376.75
1,960.20

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Sun Pharmaceutical Industries Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 24Jun 24QoQ CompSep 24YoY Comp
    Total Revenue 13,291.3912,652.755.05%13,291.39N/A
    Selling/ General/ Admin Expenses Total 2,477.702,454.620.94%2,477.70N/A
    Depreciation/ Amortization 625.91655.13-4.46%625.91N/A
    Other Operating Expenses Total 4,308.623,864.6311.49%4,308.62N/A
    Total Operating Expense 10,106.439,649.814.73%10,106.43N/A
    Operating Income 3,184.963,002.946.06%3,184.96N/A
    Net Income Before Taxes 3,597.883,423.505.09%3,597.88N/A
    Net Income 3,040.162,835.627.21%3,040.16N/A
    Diluted Normalized EPS 12.7011.807.63%12.70N/A
    Recommended For You
      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market